Experimental Treatment Pushed By ALS Patients Gets Day Before FDA, But Agency Unconvinced It Works

The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a

Related Keywords

Peter Marks ,Dan Tate ,Patricia Manhardt ,Terry Heiman Patterson ,Lou Gehrig ,Holly Fernandez Lynch ,Brian Wallach ,Marc Scheineson ,Sonya Elling ,Anthony Windebank ,Temple University ,University Of Pennsylvania ,Drug Administration ,Silver Spring ,Obama White House ,Mayo Clinic ,